MATTHEW MERIGGIOLI, M.D.
Neurology at Taylor St, Chicago, IL

License number
Illinois 036-086337
Category
Neurology
Type
Neurology
Address
Address
1740 W Taylor St, Chicago, IL 60612
Phone
(866) 600-2273
(312) 355-1528

Personal information

See more information about MATTHEW MERIGGIOLI at radaris.com
Name
Address
Phone
Matthew Meriggioli
10835 Lacrosse Ave, Oak Lawn, IL 60453
Matthew N Meriggioli, age 64
10835 Lacrosse Ave, Oak Lawn, IL 60453
(708) 424-2443
Matthew Meriggioli
850 State St, Chicago, IL 60610
Matthew N Meriggioli, age 64
120 Prospect Ave, Clarendon Hills, IL 60514
Matthew N Meriggioli, age 64
321 Park Ave, Clarendon Hills, IL 60514

Organization information

See more information about MATTHEW MERIGGIOLI at bizstanding.com

Matthew Meriggioli MD

1801 W Taylor St, Chicago, IL 60612

Industry:
Neurologist
Phone:
(312) 355-0510 (Phone)
Matthew N. Meriggioli

Professional information

Matthew Meriggioli Photo 1

Dr. Matthew Meriggioli, Chicago IL - MD (Doctor of Medicine)

Specialties:
Clinical Neurophysiology
Address:
1740 W Taylor St, Chicago 60612
(866) 600-2273 (Phone)
UNIVERSITY OF ILLINOIS NEUROLOGICAL DEPARTMENT
1801 W Taylor St SUITE 4TH, Chicago 60612
(312) 355-0510 (Phone), (312) 413-7704 (Fax)
Procedures:
EEG (Electroencephalogram), EMG (Electromyography)
Conditions:
Anterior Horn Disease, Ataxia, Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma), Cerebral Vascular Disease, Cerebrovascular Disease, Diabetic Polyneuropathy, Epilepsy, Gait Abnormality, Inflammatory and Toxic Neuropathy, Intervertebral Disc Herniation, Low Back Pain, Muscular Dystrophy (MD), Myasthenia Gravis, Parkinsonism, Peripheral Nerve Disorders, Polymyositis, Radiculopathy (not Due to Disc Displacement), Spinal Muscular Atrophy (SMA), Spinal Stenosis, Stroke, Transient Ischemic Attack (TIA), Vertigo
Certifications:
Clinical Neurophysiology, 2007, Neurology, 1995, Neuromuscular Medicine, 2008
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1740 W Taylor St, Chicago 60612
UNIVERSITY OF ILLINOIS NEUROLOGICAL DEPARTMENT
1801 W Taylor St SUITE 4TH, Chicago 60612
Sacred Heart Hospital
3240 West Franklin Blvd, Chicago 60624
University of Illinois Hospital & Health Science System
1740 West Taylor St, Chicago 60612
Education:
Medical School
Rosalind Franklin University of Medicine and Science / Chicago Medical School
Graduated: 1990
Loyola University Med Center
Northwestern Mem Hospital


Matthew N Meriggioli Photo 2

Matthew N Meriggioli, Chicago IL

Specialties:
Neurologist
Address:
1740 W Taylor St, Chicago, IL 60612
912 S Wood St, Chicago, IL 60612
Board certifications:
American Board of Psychiatry and Neurology Certification in Neurology (Psychiatry and Neurology), American Board of Psychiatry and Neurology Sub-certificate in Clinical Neurophysiology (Psychiatry and Neurology), American Board of Psychiatry and Neurology Sub-certificate in Neuromuscular Medicine (Psychiatry and Neurology)


Matthew N Meriggioli Photo 3

Matthew N Meriggioli, Chicago IL

Specialties:
Neurology, Clinical Neurophysiology, Neuromuscular Medicine, Neurological Surgery
Work:
University of Illinois at Chicago
1801 W Taylor St, Chicago, IL 60612 University of Illinois at Chicago
1740 W Taylor St, Chicago, IL 60612
Education:
Rosalind Franklin University (1990)


Matthew Meriggioli Photo 4

Regulation Of Apoptosis By Neural Specific Splice Variants Of Ig20

US Patent:
2011011, May 19, 2011
Filed:
Jul 10, 2009
Appl. No.:
13/003215
Inventors:
Bellur S. Prabhakar - Chicago IL, US
Matthew N. Meriggioli - Chicago IL, US
Liang Cheng LI - Chicago IL, US
Assignee:
The Board of Trustees of the University of Illinois - Urbana IL
International Classification:
C12N 7/01, C07H 21/02, C12N 5/079, C12N 5/10
US Classification:
4352351, 536 245, 435325
Abstract:
Pro-apoptotic signaling caused by down-modulation of KIAA0358 or expression of IG20-SV4 effectively induces spontaneous apoptosis and sensitization to TNFα-induced apoptosis in neuroblastoma cells. Methods and composition to enhance cell death in neuroblastoma are provided. Methods and compositions to reduce cell death in neurodegenerative disorders are provided.